These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7234660

  • 21. Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta.
    Graham TP, Atwood GF, Boucek RJ.
    Cathet Cardiovasc Diagn; 1978; 4(1):97-102. PubMed ID: 77192
    [Abstract] [Full Text] [Related]

  • 22. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT, Norton JB, Readinger RI, Sotomora RF.
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract] [Full Text] [Related]

  • 23. Neurological and electroencephalographic changes in newborns treated with prostaglandins E1 and E2.
    Fariello R, Olley PM, Coceani F.
    Prostaglandins; 1977 May; 13(5):901-7. PubMed ID: 866697
    [Abstract] [Full Text] [Related]

  • 24. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML.
    Adv Prostaglandin Thromboxane Res; 1978 May; 4():355-62. PubMed ID: 347914
    [Abstract] [Full Text] [Related]

  • 25. Care of the infant with ductus-dependent congenital heart disease receiving prostaglandin E1.
    Stachura L.
    Issues Compr Pediatr Nurs; 1984 May; 7(4-5):203-15. PubMed ID: 6569057
    [No Abstract] [Full Text] [Related]

  • 26. Prostaglandins and the management of congenital heart disease.
    Taylor WJ, Alpert BS.
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [Abstract] [Full Text] [Related]

  • 27. Prostaglandin E1 infusion in the hypoplastic left heart syndrome.
    Yabek SM, Mann JS.
    Chest; 1979 Sep; 76(3):330-1. PubMed ID: 467122
    [Abstract] [Full Text] [Related]

  • 28. Prostaglandin E1 infusion: successful initial treatment.
    Linday L, Levin AR, Reitman M, Engle MA.
    N Y State J Med; 1981 Feb; 81(2):218-21. PubMed ID: 6936640
    [No Abstract] [Full Text] [Related]

  • 29. THE ROENTGENOLOGIC FINDINGS IN COMMON VENTRICLE WITH TRANSPOSITION OF THE GREAT VESSELS.
    ELLIOTT LP, GEDGAUDAS E.
    Radiology; 1964 May; 82():850-65. PubMed ID: 14153676
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K.
    Ugeskr Laeger; 1979 Jul 09; 141(28):1915-6. PubMed ID: 473414
    [No Abstract] [Full Text] [Related]

  • 31. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD.
    Adv Prostaglandin Thromboxane Res; 1978 Jul 09; 4():383-5. PubMed ID: 645513
    [No Abstract] [Full Text] [Related]

  • 32. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M, Hövels-Gürich H, von Bernuth G.
    Rofo; 1984 Oct 09; 141(4):427-30. PubMed ID: 6436918
    [Abstract] [Full Text] [Related]

  • 33. Role of prostaglandin E1 infusion in the management of transposition of the great arteries.
    Benson LN, Olley PM, Patel RG, Coceani F, Rowe RD.
    Am J Cardiol; 1979 Oct 09; 44(4):691-6. PubMed ID: 484498
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus.
    Carroll SJ, Ferris A, Chen J, Liberman L.
    Pediatr Cardiol; 2006 Oct 09; 27(6):766-8. PubMed ID: 17111291
    [Abstract] [Full Text] [Related]

  • 35. Editorial: Nonsurgical palliation of congenital heart malformations.
    Olley PM.
    N Engl J Med; 1975 Jun 12; 292(24):1292-4. PubMed ID: 48193
    [No Abstract] [Full Text] [Related]

  • 36. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.
    Neutze JM, Starling MB, Elliott RB, Barratt-Boyes BG.
    Circulation; 1977 Feb 12; 55(2):238-41. PubMed ID: 64317
    [Abstract] [Full Text] [Related]

  • 37. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F, Bozio A, Andre M, Jocteur-Monrozier D, Champsaur G, Normand J.
    Pediatrie; 1984 Jun 12; 39(4):245-52. PubMed ID: 6504667
    [Abstract] [Full Text] [Related]

  • 38. THE SURGICAL ASPECTS OF HEART DISEASE UNDER THE AGE OF TWO YEARS.
    GERBODE F, O'BRIEN MF, KERTH WJ, ROBINSON SJ.
    J Cardiovasc Surg (Torino); 1964 Jun 12; 5():591-607. PubMed ID: 14241021
    [No Abstract] [Full Text] [Related]

  • 39. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.
    Silver MM, Freedom RM, Silver MD, Olley PM.
    Hum Pathol; 1981 Dec 12; 12(12):1123-36. PubMed ID: 7199511
    [Abstract] [Full Text] [Related]

  • 40. Prostaglandin E1 in suspected ductus dependent cardiac malformation.
    Hallidie-Smith KA.
    Arch Dis Child; 1984 Nov 12; 59(11):1020-6. PubMed ID: 6542338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.